That’s what I thought, it will be great if the insurances also cover the off-label use of Ryoncil for SR-aGvHD in adult. In this case, an obvious requirement would be that all other FDA approved line of treatments, including Rux, had already been tried and didn’t work to change the course of disease progression.
MSB Price at posting:
$2.80 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)